| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.17 | 0.01 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.077 | 0.2 |